Stocksigma LogoStocksigma Logo

Ipca Laboratories Posts Strong Q2 FY27 With Consolidated Net Profit Rising 33% YoY

Ipca Laboratories reported a 14% YoY increase in consolidated revenue from operations to Rs 2,909.94 crore for Q2 ended 30th Sep'26

Ipca Laboratories Posts Strong Q2 FY27 With Consolidated Net Profit Rising 33% YoY

Ipca Laboratories Ltd 路 Financial Result 路 05 Nov 2026, 7:18 pm

Ipca Laboratories Posts Strong Q2 FY27 With Consolidated Net Profit Rising 33% YoY Ipca Laboratories reported a 14% YoY increase in consolidated revenue from operations to Rs 2,909.94 crore for Q2 ended 30th Sep'26. Consolidated net profit attributable to owners rose 33% YoY to Rs 375.13 crore, driven by a 21% YoY rise in operating EBITDA to Rs 668.27 crore, with EBITDA margin expanding 129 bps YoY to 22.97%. Results include an exceptional provision of Rs 24.26 crore for UK litigation claims. Domestic formulation sales grew 14% YoY to Rs 1,157.20 crore, while total exports expanded 17% YoY.

Original exchange filing (PDF)

More announcements from Ipca Laboratories Ltd

All Ipca Laboratories Ltd announcements